Cargando…
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650200/ https://www.ncbi.nlm.nih.gov/pubmed/34879241 http://dx.doi.org/10.1016/j.cmet.2021.10.014 |
| _version_ | 1784611152106356736 |
|---|---|
| author | Reiterer, Moritz Rajan, Mangala Gómez-Banoy, Nicolás Lau, Jennifer D. Gomez-Escobar, Luis G. Ma, Lunkun Gilani, Ankit Alvarez-Mulett, Sergio Sholle, Evan T. Chandar, Vasuretha Bram, Yaron Hoffman, Katherine Bhardwaj, Priya Piloco, Phoebe Rubio-Navarro, Alfonso Uhl, Skyler Carrau, Lucia Houhgton, Sean Redmond, David Shukla, Alpana P. Goyal, Parag Brown, Kristy A. tenOever, Benjamin R. Alonso, Laura C. Schwartz, Robert E. Schenck, Edward J. Safford, Monika M. Lo, James C. |
| author_facet | Reiterer, Moritz Rajan, Mangala Gómez-Banoy, Nicolás Lau, Jennifer D. Gomez-Escobar, Luis G. Ma, Lunkun Gilani, Ankit Alvarez-Mulett, Sergio Sholle, Evan T. Chandar, Vasuretha Bram, Yaron Hoffman, Katherine Bhardwaj, Priya Piloco, Phoebe Rubio-Navarro, Alfonso Uhl, Skyler Carrau, Lucia Houhgton, Sean Redmond, David Shukla, Alpana P. Goyal, Parag Brown, Kristy A. tenOever, Benjamin R. Alonso, Laura C. Schwartz, Robert E. Schenck, Edward J. Safford, Monika M. Lo, James C. |
| author_sort | Reiterer, Moritz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8650200 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86502002021-12-07 Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 Reiterer, Moritz Rajan, Mangala Gómez-Banoy, Nicolás Lau, Jennifer D. Gomez-Escobar, Luis G. Ma, Lunkun Gilani, Ankit Alvarez-Mulett, Sergio Sholle, Evan T. Chandar, Vasuretha Bram, Yaron Hoffman, Katherine Bhardwaj, Priya Piloco, Phoebe Rubio-Navarro, Alfonso Uhl, Skyler Carrau, Lucia Houhgton, Sean Redmond, David Shukla, Alpana P. Goyal, Parag Brown, Kristy A. tenOever, Benjamin R. Alonso, Laura C. Schwartz, Robert E. Schenck, Edward J. Safford, Monika M. Lo, James C. Cell Metab Correction Elsevier Inc. 2021-12-07 2021-12-07 /pmc/articles/PMC8650200/ /pubmed/34879241 http://dx.doi.org/10.1016/j.cmet.2021.10.014 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correction Reiterer, Moritz Rajan, Mangala Gómez-Banoy, Nicolás Lau, Jennifer D. Gomez-Escobar, Luis G. Ma, Lunkun Gilani, Ankit Alvarez-Mulett, Sergio Sholle, Evan T. Chandar, Vasuretha Bram, Yaron Hoffman, Katherine Bhardwaj, Priya Piloco, Phoebe Rubio-Navarro, Alfonso Uhl, Skyler Carrau, Lucia Houhgton, Sean Redmond, David Shukla, Alpana P. Goyal, Parag Brown, Kristy A. tenOever, Benjamin R. Alonso, Laura C. Schwartz, Robert E. Schenck, Edward J. Safford, Monika M. Lo, James C. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 |
| title | Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 |
| title_full | Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 |
| title_fullStr | Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 |
| title_full_unstemmed | Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 |
| title_short | Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 |
| title_sort | hyperglycemia in acute covid-19 is characterized by insulin resistance and adipose tissue infectivity by sars-cov-2 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650200/ https://www.ncbi.nlm.nih.gov/pubmed/34879241 http://dx.doi.org/10.1016/j.cmet.2021.10.014 |
| work_keys_str_mv | AT reiterermoritz hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT rajanmangala hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT gomezbanoynicolas hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT laujenniferd hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT gomezescobarluisg hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT malunkun hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT gilaniankit hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT alvarezmulettsergio hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT sholleevant hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT chandarvasuretha hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT bramyaron hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT hoffmankatherine hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT bhardwajpriya hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT pilocophoebe hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT rubionavarroalfonso hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT uhlskyler hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT carraulucia hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT houhgtonsean hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT redmonddavid hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT shuklaalpanap hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT goyalparag hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT brownkristya hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT tenoeverbenjaminr hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT alonsolaurac hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT schwartzroberte hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT schenckedwardj hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT saffordmonikam hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 AT lojamesc hyperglycemiainacutecovid19ischaracterizedbyinsulinresistanceandadiposetissueinfectivitybysarscov2 |